Why Anavex Life Sciences Stock Soared 35% Today

Shares of Anavex Life Sciences (NASDAQ: AVXL) got a serious boost on Monday. Two of the company's leading pipeline drugs were positively highlighted in peer-reviewed research that was newly published in a medical journal, and the shares rose to close the day over 35% higher.

Late last week, the medical journal of Expert Opinion on Therapeutic Targets published research stating that two of Anavex's treatments for several afflictions related to the central nervous system, such as Alzheimer's, could be very effective in one aspect of fighting such diseases.

Image source: Getty Images.

Continue reading

Source Fool.com